IRCCS Centro Cardiologico Monzino

Milan, Lombardy 20138

0 studies enrolling now · 2 studies all time

What they study most

Atrial Fibrillation, Chronic Heart Failure With Reduced Ejection Fraction, Prevention of Stroke or Systemic Embolism

Studies at this site

• A Study to Learn How Safe Starting Vericiguat at a Dose of 5 Milligrams is in Participants With Chronic Heart Failure With Reduced Ejection Fraction — Completed
• A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke — Stopped early